v3.26.1
Leases
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Leases    
Leases

8.

Leases:

Lease balances consisted of the following:

  ​ ​ ​

June 30, 2026

  ​ ​ ​

December 31, 2025

Right-of-use assets

$

2,706

$

2,918

Lease liabilities, current

$

390

$

454

Lease liabilities, non-current

 

3,875

 

4,233

Total operating lease liabilities

$

4,265

$

4,687

The Company leases its office and lab facilities and certain office equipment under non-cancellable operating leases with various lease terms. As of June 30, 2026, non-cancellable leases expire at the end of 2032.

As of June 30, 2026, the weighted average remaining lease term is 6.5 years (2025 – 7.0 years).

8.

Leases (continued):

As the implicit rate is not available to the Company, it determined its incremental borrowing rate and used this as the discount rate for its lease calculations. The incremental borrowing rate is based on the Company’s borrowing rate and adjusted for payment structure, the securitized nature of the lease, the term of the lease and the economic environment of the lease. As of June 30, 2026, the weighted average discount rate was 11.35% (December 31, 2025 - 11.35%).

Maturities of operating lease liabilities were as follows as of June 30, 2026:

Fiscal year ending:

  ​ ​ ​

  ​

2026

  ​ ​ ​

$

413

2027

 

838

2028

 

947

2029

 

947

Thereafter

 

2,841

Future minimum payments

 

5,986

Impact of discounting

 

(1,721)

Total

$

4,265

8.Leases:

Lease balances consisted of the following:

As of December 31

  ​ ​ ​

2025

  ​ ​ ​

2024

Right-of-use assets

 

$

2,918

 

$

3,278

Lease liabilities, current

 

$

454

 

$

597

Lease liabilities, non-current

4,233

4,410

Total operating lease liabilities

 

$

4,687

 

$

5,007

The Company leases its office and lab facilities and certain office equipment under non-cancellable operating leases with various lease terms. As of December 31, 2025, non-cancellable leases expire at the end of 2032.

The Company’s office and lab facilities leases include renewal options to extend the lease term from five to nine years. The Company has not included any renewal options when calculating the lease periods as these options are not reasonably certain of being exercised. The lease agreements do not contain any material residual value guarantees or material restrictive covenants.

The Company recognizes operating lease costs on a straight-line basis over the lease period. Operating lease costs for short-term leases were not material during the years ended December 31, 2025 and 2024. Operating lease expense incurred for the years ended December 31, 2025 and 2024 was $757 and $960, respectively, of which $226 and $352, respectively, consisted of the depreciation of right-of-use assets.

8.

Leases: (continued)

At December 31, 2025, the weighted average remaining lease term is 7 years (2024 7.5 years).

As the implicit rate is not available to the Company, it determined its IBR and used this as the discount rate for its lease calculations. The IBR is based on the Companys borrowing rate and adjusted for payment structure, the securitized nature of the lease, the term of the lease and the economic environment of the lease. At December 31, 2025, the weighted average discount rate was 11.35% (2024 - 11.15%).

Maturities of operating lease liabilities were as follows as of December 31, 2025:

Fiscal year ending:

  ​ ​ ​

2026

 

$

933

2027

870

2028

983

2029

983

2030

983

Thereafter

1,966

Future minimum payments

6,718

Impact of discounting

(2,031)

Total

 

$

4,687